Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

385 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions.
Humberstone AJ, Currie GJ, Porter CJ, Scanlon MJ, Charman WN. Humberstone AJ, et al. J Pharm Biomed Anal. 1995 Mar;13(3):265-72. doi: 10.1016/0731-7085(95)01256-k. J Pharm Biomed Anal. 1995. PMID: 7619886
Model systems for intestinal lymphatic transport studies.
Porter CJ, Charman WN. Porter CJ, et al. Pharm Biotechnol. 1996;8:85-102. doi: 10.1007/978-1-4899-1863-5_6. Pharm Biotechnol. 1996. PMID: 8791806 Review. No abstract available.
Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
Porter CJ, Charman SA, Humberstone AJ, Charman WN. Porter CJ, et al. J Pharm Sci. 1996 Apr;85(4):357-61. doi: 10.1021/js9502229. J Pharm Sci. 1996. PMID: 8901068
Differences in pre- and post-prandial plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from beagle dog plasma.
Porter CJ, Caliph SM, Charman WN. Porter CJ, et al. J Pharm Biomed Anal. 1997 Sep;16(1):175-80. doi: 10.1016/s0731-7085(97)00008-3. J Pharm Biomed Anal. 1997. PMID: 9447565 No abstract available.
Drug delivery to the lymphatic system.
Porter CJ. Porter CJ. Crit Rev Ther Drug Carrier Syst. 1997;14(4):333-93. Crit Rev Ther Drug Carrier Syst. 1997. PMID: 9450175 Review.
Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
Wasan KM, Ramaswamy M, McIntosh MP, Porter CJ, Charman WN. Wasan KM, et al. J Pharm Sci. 1999 Feb;88(2):185-90. doi: 10.1021/js980353k. J Pharm Sci. 1999. PMID: 9950636
385 results
Jump to page
Feedback